Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors

NCT00804310 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: ixabepilone
DRUG: lapatinib ditosylate

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]
[object Object]